Please assess the completion status of the following clinical trial:

Trial Title: Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* end stage degenerative joint disease~* enrolled for unilateral total knee arthroplasty at the University of Chicago~* age \< 85~* ability to understand and willingness to sign a written informed consent~Exclusion Criteria:~* age \> 85~* American Society of Anesthesiologists physical status \> 3~* known hypersensitivity to lidocaine, bupivacaine, ropivacaine or other local anesthetic agents~* Coagulopathy, specifically INR \> 1.5, Platelets \< 100, therapy with clopidogrel within 5 days prior to surgery, enoxaparin or fondaparinux within the last 24 hours prior to surgery, patients with anti-phospholipid syndrome requiring aggressive anticoagulation perioperatively~* History of alcohol or substance abuse (including strong opioids - morphine, oxycodone, methadone, fentanyl, ketobemidone), taking \> 50 mg morphine equivalent daily of opioids~* Pre-existing femoral neuropathy or radiculopathy~* Patients with poor ability to communicate

- Gender: ALL
- Minimum Age: None
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Epidural Catheter without Adductor Canal Nerve Block Catheter (Type: SHAM_COMPARATOR): Patients randomized to the sham catheter will have a sham catheter placed on the skin and obscured with an opaque dressing and attached to a functional pump which will not be turned on.
- Epidural Catheter with Adductor Canal Nerve Block Catheter (Type: EXPERIMENTAL): Patients will receive a continuous adductor canal block placed under ultrasound guidance under the supervision of an attending physician who is fellowship trained.

Based on this trial design, predict the completion outcome and termination type (if applicable).